Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
01 May 2007Website:
http://www.oramed.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 18:13:34 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Oramed Pharmaceuticals?
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.
What sector is Oramed Pharmaceuticals in?
Oramed Pharmaceuticals is in the Healthcare sector
What industry is Oramed Pharmaceuticals in?
Oramed Pharmaceuticals is in the Biotechnology industry
What country is Oramed Pharmaceuticals from?
Oramed Pharmaceuticals is headquartered in United States
When did Oramed Pharmaceuticals go public?
Oramed Pharmaceuticals initial public offering (IPO) was on 01 May 2007
What is Oramed Pharmaceuticals website?
https://www.oramed.com
Is Oramed Pharmaceuticals in the S&P 500?
No, Oramed Pharmaceuticals is not included in the S&P 500 index
Is Oramed Pharmaceuticals in the NASDAQ 100?
No, Oramed Pharmaceuticals is not included in the NASDAQ 100 index
Is Oramed Pharmaceuticals in the Dow Jones?
No, Oramed Pharmaceuticals is not included in the Dow Jones index
When does Oramed Pharmaceuticals report earnings?
The next expected earnings date for Oramed Pharmaceuticals is 09 August 2024